zorifertinib 
Alpha Biopharma
['everest']
everest: azd3759 (zorifertinib) vs gef/erlo in cns+ (8% lmd) with strong pfs benefit. t790m is commonest resistance mech. egfrwt toxicities predominant- like 2nd gen tkis. q is it s role if osi/lazer available: imho only role if 3rd gen unavailable #asco23 
Thoracic Oncologist @royalmarsdenNHS, Professor @ICR_London; Chair @BTOGorg; views are my own.